Cheap drugs may tame severe sun allergy
NCT ID NCT06476366
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested two older, low-cost drugs—methotrexate and azathioprine—against chronic actinic dermatitis, a painful skin reaction to sunlight. Fifty adults were randomly assigned to one drug for 24 weeks. Researchers tracked eczema severity and safety. The goal was to see if either drug could control the disease without steroids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Methotrexate and azathioprine
- What this could lead to
- If one drug proves safer or more effective, it could become a standard, affordable treatment for chronic actinic dermatitis.
- What could go wrong
- This is a very small, early-phase trial (50 participants) from a single military hospital. Results may not apply to broader populations, and both drugs have known side effects like liver toxicity and bone marrow suppression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ACTINIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, Pakistan